Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FX1ZX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,147
Award facts
- Contract value 100% obligated
- $12,146.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under a firm fixed-price contract valued at $12,146.79. The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million through November 2026, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group maintains a robust portfolio of federal pharmaceutical supply contracts with the Defense Logistics Agency, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's established status as a woman-owned small business and its proven capability to deliver specialized pharmaceutical products, including oncology treatments and specialty medications, position it as a critical supplier within the federal pharmaceutical supply chain. This delivery order for Jakafi tablets represents a routine pharmaceutical procurement supporting the ongoing medical supply needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FX1ZX?
SPE2DB25FX1ZX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FX1ZX worth?
The government has obligated $12,147 on SPE2DB25FX1ZX.
Is contract SPE2DB25FX1ZX an order under another contract?
Yes. SPE2DB25FX1ZX is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1ZX competed?
The extent of competition for SPE2DB25FX1ZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award